Zhengrui Li

1.5k total citations
59 papers, 580 citations indexed

About

Zhengrui Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhengrui Li has authored 59 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhengrui Li's work include Oral microbiology and periodontitis research (8 papers), Oral Health Pathology and Treatment (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Zhengrui Li is often cited by papers focused on Oral microbiology and periodontitis research (8 papers), Oral Health Pathology and Treatment (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Zhengrui Li collaborates with scholars based in China, Hungary and United States. Zhengrui Li's co-authors include Ling Zhang, Xufeng Huang, Qi Wang, Rao Fu, Xu‐Feng Huang, Juan Su, Xiaoyu Gu, Yuan Liu, Yidan Tang and Jing Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Zhengrui Li

48 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengrui Li China 15 181 158 113 97 91 59 580
Tomoaki Shintani Japan 15 228 1.3× 154 1.0× 68 0.6× 122 1.3× 78 0.9× 66 634
Jiongke Wang China 11 303 1.7× 100 0.6× 93 0.8× 178 1.8× 80 0.9× 39 582
Aline Corrêa Abrahão Brazil 14 244 1.3× 173 1.1× 79 0.7× 103 1.1× 57 0.6× 59 662
Abdelhakim Salem Finland 16 289 1.6× 158 1.0× 48 0.4× 118 1.2× 129 1.4× 41 788
María Teresa Gutiérrez‐Salmerón Spain 17 233 1.3× 85 0.5× 44 0.4× 82 0.8× 104 1.1× 22 771
Sheng Wen China 14 416 2.3× 175 1.1× 57 0.5× 193 2.0× 61 0.7× 38 796
Junhui Huang China 12 174 1.0× 89 0.6× 51 0.5× 85 0.9× 59 0.6× 29 372
Xinyuan Zhao China 17 522 2.9× 86 0.5× 78 0.7× 312 3.2× 65 0.7× 36 749
Hiroki Nagayasu Japan 13 214 1.2× 148 0.9× 47 0.4× 67 0.7× 59 0.6× 47 512
Anita Gohel United States 12 239 1.3× 126 0.8× 35 0.3× 49 0.5× 78 0.9× 29 714

Countries citing papers authored by Zhengrui Li

Since Specialization
Citations

This map shows the geographic impact of Zhengrui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengrui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengrui Li more than expected).

Fields of papers citing papers by Zhengrui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengrui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengrui Li. The network helps show where Zhengrui Li may publish in the future.

Co-authorship network of co-authors of Zhengrui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengrui Li. A scholar is included among the top collaborators of Zhengrui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengrui Li. Zhengrui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhengrui, Aimin Jiang, Jinghong Chen, et al.. (2025). Immunotherapy-induced cholestasis in cancer: insights from the two real-world pharmacovigilance databases of FAERS and VigiBase. International Journal of Surgery. 111(8). 5105–5121. 2 indexed citations
2.
Gopinath, Divya, et al.. (2025). Role of Oral Microbes in Epithelial‐Mesenchymal Transition in Cancer Progression. Molecular Oral Microbiology. 40(5). 191–201. 1 indexed citations
3.
Jiang, Aimin, Qi Wang, Zhengrui Li, et al.. (2025). Cloud‐Based GWAS Platform: An Innovative Solution for Efficient Acquisition and Analysis of Genomic Data. SHILAP Revista de lepidopterología. 1(3). 397–411.
4.
Liu, Jian, Rao Fu, Su Yang, et al.. (2025). Applications of artificial intelligence in cancer immunotherapy: a frontier review on enhancing treatment efficacy and safety. Frontiers in Immunology. 16. 1676112–1676112.
5.
Lin, Anqi, Aimin Jiang, Xufeng Huang, et al.. (2025). The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events. SHILAP Revista de lepidopterología. 1(3). 322–358. 2 indexed citations
6.
Liu, Jian, et al.. (2025). The Impact of Dietary Patterns on the Human Gut Microbiome and Its Health Significance: A Review. The FASEB Journal. 39(19). e71072–e71072.
7.
Li, Lei, Yidan Tang, Ling Qiu, Zhengrui Li, & Ruo Wang. (2025). Extracellular matrix shapes cancer stem cell behavior in breast cancer: a mini review. Frontiers in Immunology. 15. 1503021–1503021. 2 indexed citations
8.
Lin, Anqi, Zhengrui Li, Aimin Jiang, et al.. (2025). Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence. Biomarker Research. 13(1). 50–50. 14 indexed citations
9.
Li, Zhengrui, Xufeng Huang, Qi Wang, & Divya Gopinath. (2025). Causal Association Between Microbiome and Oral-Oropharyngeal Cancer: A Mendelian Randomization Study. International Dental Journal. 75(3). 1897–1905. 5 indexed citations
10.
Huang, Xufeng, et al.. (2024). Disulfidptosis in head and neck squamous carcinoma: Integrative bioinformatic and in‐vitro analysis. Oral Diseases. 30(8). 4993–5006. 2 indexed citations
11.
Gu, Xiaoyu, Zhengrui Li, & Juan Su. (2024). Air pollution and skin diseases: A comprehensive evaluation of the associated mechanism. Ecotoxicology and Environmental Safety. 278. 116429–116429. 36 indexed citations
12.
Wang, Zhan, Shuai Yang, Zhengrui Li, et al.. (2024). Possible mechanisms of SARS-CoV-2-associated myocardial fibrosis: reflections in the post-pandemic era. Frontiers in Microbiology. 15. 1470953–1470953. 2 indexed citations
13.
Wang, Qi, Zhengrui Li, Jiaheng Xie, et al.. (2024). Bridging Chronic Inflammation and Digestive Cancer: The Critical Role of Innate Lymphoid Cells in Tumor Microenvironments. International Journal of Biological Sciences. 20(12). 4799–4818. 22 indexed citations
14.
Wu, Yanming, et al.. (2024). Research progress of the Otubains subfamily in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 179. 117348–117348. 1 indexed citations
15.
Zhou, Zhaokai, Ge Zhang, Shuai Yang, et al.. (2024). The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?. Cancer Letters. 597. 217083–217083. 12 indexed citations
16.
Li, Zhengrui, et al.. (2023). Oral microbiota may affect osteoradionecrosis following radiotherapy for head and neck cancer. Journal of Translational Medicine. 21(1). 391–391. 14 indexed citations
17.
Li, Zhengrui, et al.. (2023). Network analysis reveals miRNA crosstalk between periodontitis and oral squamous cell carcinoma. BMC Oral Health. 23(1). 19–19. 6 indexed citations
18.
Li, Zhengrui, et al.. (2023). A decade of progress: bibliometric analysis of trends and hotspots in oral microbiome research (2013-2022). Frontiers in Cellular and Infection Microbiology. 13. 12 indexed citations
19.
Li, Zhengrui, et al.. (2023). Halitosis: etiology, prevention, and the role of microbiota. Clinical Oral Investigations. 27(11). 6383–6393. 21 indexed citations
20.
Li, Zhengrui, et al.. (2023). The significant clinical correlation of the intratumor oral microbiome in oral squamous cell carcinoma based on tissue-derived sequencing. Frontiers in Physiology. 13. 1089539–1089539. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026